Prime Medicine, Inc. (PRME) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q2 EPS of ($0.24), $0.12 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $1.15 million.
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan upgrades Kraft Heinz credit to Overweight on deleveraging outlook
- Loar Holdings Inc. (LOAR) Reports Q2 EPS of $0.38 ; Offers Guidance
- Airship AI Holdings (AISP) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
